(Q38447333)

3 September 2017

Correlation between MIB1-determined tumor growth fraction and incidence of tumor recurrence in early ovarian carcinomas (English)

1 reference

3 September 2017

Karsten Münstedt

1

1 reference

3 September 2017

Richard von Georgi

series ordinal

2

1 reference

3 September 2017

Folker E Franke

series ordinal

3

1 reference

3 September 2017

language of work or name

1 reference

1 January 2004

1 reference

3 September 2017

1 reference

3 September 2017

22

1 reference

3 September 2017

2

1 reference

3 September 2017

185-194

1 reference

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

3 September 2017

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030206

Ovarian cancer: should we be managing patients with good and bad prognostic factors in the same manner?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030206

Influence of surgery and postoperative therapy and tumor characteristics on patient prognosis in advanced ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030206

Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030206

Advances in ovarian cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030206

An evaluation of prognostic factors in advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030206

Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030206

Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030206

Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030206

An evaluation of CA125, CA1 and peanut lectin immunoreactivity in epithelial ovarian neoplasms: correlation with histopathological features, prognostic variables and patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030206

Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030206

Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030206

The combined evaluation ofp53 accumulation and of Ki-67 (MIBI) labelling index provides independent information on overall survival of ovarian carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030206

Multivariate analysis of prognostic factors in patients with ovarian cancer stage I and II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030206

Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030206

Natural history and prognosis of untreated stage I epithelial ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030206

Randomized trial comparing cisplatin with radioactive phosphorus or whole-abdomen irradiation as adjuvant treatment of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030206

Interobserver reproducibility of histopathological features in stage II breast cancer. An ECOG study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030206

21 January 2018

Identifiers

DOI

10.1081/CNV-120030206

1 reference

3 September 2017

1 reference